MARLBOROUGH, Mass., Sept. 17, 2024 /PRNewswire/ -- Boston Scientific Corporation (BSX) has received U.S. Food and Drug Administration (FDA) approval to expand the indication for current-generation ...
Abbott's UltiPace™ Pacing Lead is the first FDA-approved stylet-driven lead indicated for left bundle branch area placement. Recently, the U.S. Food and Drug Administration (FDA) granted Breakthrough ...
SAN FRANCISCO, CA—Attendees of Heart Rhythm 2022 heard results from numerous studies investigating the impact of conduction-system pacing, which includes both His-bundle and left bundle branch (LBB) ...
Medtronic has secured a new approval from the FDA that expands the flexibility of its pacemaker hardware, allowing it to tap into the heart’s natural electrical signals. Known as conduction system ...
LAKE OSWEGO, Ore., Dec. 12, 2022 /PRNewswire/ -- BIOTRONIK, a global leader in the treatment of cardiac and vascular disease is pleased to announce the first patient enrollment in BIO-CONDUCT, an FDA ...
Medtronic "Conduction System Pacing" Expanded Indication Now Includes Left Bundle Branch Area Pacing in Addition to His-Bundle Pacing for Patients with Slow Heart Rates Medtronic is the first and only ...
“It is estimated that 1.4 million patients worldwide will receive a pacemaker in 2023,” said first author Professor Haran Burri of the University Hospital of Geneva, Switzerland. 4 “Approximately half ...
Please provide your email address to receive an email when new articles are posted on . Left bundle branch pacing was achieved for the first time via leadless pacemaker. Implantation failure rate was ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback